[Form 4] uniQure N.V. Insider Trading Activity

Rhea-AI Filing Summary

uniQure director Rachelle Suzanne Jacques reported a non-discretionary sale of 2,112 ordinary shares on June 20, 2025 at a weighted average price of $14.45 per share (range: $14.40-$14.50).

Key details of the transaction:

• The sale was automatically executed to cover estimated withholding taxes upon vesting of restricted share units
• Transaction was made according to automatic sale instructions in the Restricted Share Unit Agreement
• Following the transaction, Jacques continues to hold 28,346 ordinary shares directly
• The filing was signed by Christian Klemt as attorney-in-fact on June 24, 2025

This transaction represents a routine tax-related share sale rather than a discretionary trading decision by the insider.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Jacques Rachelle Suzanne

(Last) (First) (Middle)

C/O UNIQURE N. V.

PAASHEUVELWEG 25A

(Street)

AMSTERDAM P7 11058BP

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
uniQure N.V. [ QURE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
06/20/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	06/20/2025		S(1)		2,112(1)	D	$14.45(2)	28,346	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person.

2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.40 to $14.50. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

	/s/ Christian Klemt, Attorney-in-Fact	06/24/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many QURE shares did Director Jacques Rachelle Suzanne sell on June 20, 2025?

Director Jacques Rachelle Suzanne sold 2,112 ordinary shares of QURE on June 20, 2025 at a weighted average price of $14.45 per share.

What was the reason for QURE director's stock sale in June 2025?

The shares were sold automatically upon the vesting of restricted share units solely to cover estimated withholding taxes. This was not a discretionary trade by the director, but rather an automatic sale pursuant to instructions in the Restricted Share Unit Agreement.

How many QURE shares does Jacques Rachelle Suzanne own after the June 2025 transaction?

Following the reported transaction, Jacques Rachelle Suzanne directly owns 28,346 ordinary shares of QURE.

What was the price range of QURE shares sold in the June 2025 insider transaction?

The shares were sold in multiple transactions at prices ranging from $14.40 to $14.50, with a weighted average price of $14.45 per share.

Who executed the Form 4 filing for QURE's insider transaction?

The Form 4 was signed by Christian Klemt as Attorney-in-Fact on June 24, 2025, on behalf of the reporting person Jacques Rachelle Suzanne.